» Articles » PMID: 2862901

Effects of Nicardipine on Cardiac Volume at Rest and During Exercise-induced Angina

Overview
Specialty Pharmacology
Date 1985 Jan 1
PMID 2862901
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

The action of nicardipine on cardiac volume, both at rest and during exercise-induced angina, was evaluated in 12 patients with angiographically-proven coronary artery disease. Nicardipine given to patients at rest reduced systemic vascular resistance and mean arterial pressure and increased heart rate and cardiac index. The left ventricular filling pressure, ejection fraction (EF), end-diastolic and end-systolic volumes were unchanged. During supine bicycle exercise, the reduction in systemic arterial blood pressure following nicardipine increased cardiac and stroke index and attenuated the rise in left ventricular filling pressure observed in the control exercise. The effects of nicardipine on EF, end-diastolic and end-systolic cardiac volumes were dependent on the baseline cardiac reserve. In patients with EF less than 50%, nicardipine improved EF and left ventricular exercise volumes.

Citing Articles

Management of systemic and pulmonary hypertension.

Levy J Tex Heart Inst J. 2006; 32(4):467-71.

PMID: 16429888 PMC: 1351815.


Hemodynamic effects of intravenous elgodipine in coronary artery disease during rest and exercise, and basic pharmacokinetic parameters.

Silke B, de la Motte S, Spiers P, Herity N, Drake M, Kelly J Cardiovasc Drugs Ther. 1996; 10(5):573-80.

PMID: 8950073 DOI: 10.1007/BF00050999.


'Second generation' dihydropyridine calcium antagonists. Greater vascular selectivity and some unique applications.

Freedman D, Waters D Drugs. 1987; 34(5):578-98.

PMID: 3319491 DOI: 10.2165/00003495-198734050-00005.


Nicardipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in the treatment of angina pectoris, hypertension and related cardiovascular disorders.

Sorkin E, Clissold S Drugs. 1987; 33(4):296-345.

PMID: 3297616 DOI: 10.2165/00003495-198733040-00002.


Haemodynamic and radionuclide effects of amlodipine in coronary artery disease.

Silke B, Verma S, Zezulka A, Sharma S, Reynolds G, Jackson N Br J Clin Pharmacol. 1990; 29(4):437-45.

PMID: 2139339 PMC: 1380114. DOI: 10.1111/j.1365-2125.1990.tb03662.x.

References
1.
PARKER J, DI GIORGI S, West R . A hemodynamic study of acute coronary insufficiency precipitated by exercise. With observations on the effects of nitroglycerin. Am J Cardiol. 1966; 17(4):470-83. DOI: 10.1016/0002-9149(66)90237-2. View

2.
Silke B, Verma S, Nelson G, Hussain M, Taylor S . Haemodynamic dose-response effects of i.v. nicardipine in coronary artery disease. Br J Clin Pharmacol. 1984; 18(5):717-24. PMC: 1463544. DOI: 10.1111/j.1365-2125.1984.tb02534.x. View

3.
Braunwald E . Control of myocardial oxygen consumption: physiologic and clinical considerations. Am J Cardiol. 1971; 27(4):416-32. DOI: 10.1016/0002-9149(71)90439-5. View

4.
Ferlinz J, Easthope J, Aronow W . Effects of verapamil on myocardial performance in coronary disease. Circulation. 1979; 59(2):313-9. DOI: 10.1161/01.cir.59.2.313. View

5.
Klugmann S, Salvi A, Camerini F . Haemodynamic effects of nifedipine in heart failure. Br Heart J. 1980; 43(4):440-6. PMC: 482309. DOI: 10.1136/hrt.43.4.440. View